| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/16/2002 | US6372434 Methods for reducing the complexity of DNA sequences |
| 04/16/2002 | US6372433 Antisense modulation of inhibitor of DNA binding-1 expression |
| 04/16/2002 | US6372432 Taking sample of blood cells from subject; preparing nucleic acids from sample; hybridizing nucleic acids with nucleic acid library in order to obtain a hybridization profile, detecting presence of cancer or neurodegenerative disease |
| 04/16/2002 | US6372431 Mammalian toxicological response markers |
| 04/16/2002 | US6372429 Providing double stranded dna fragment having terminal single stranded overhang having 15-30 bases and double stranded dna fragment; mixing first and second dna fragments to promote specific joining thereof |
| 04/16/2002 | US6372427 Cooperative oligonucleotides |
| 04/16/2002 | US6372425 Large scale affinity chromatography of macromolecules |
| 04/16/2002 | US6372424 Rapid detection and identification of pathogens |
| 04/16/2002 | US6372422 Creating superovulation in non-human female mammal to create eggs by using an ovulatory pharmaceutical; determining sex of sperm cell of male mammal; sorting according to sex of sperm cells; inserting into uterus; fertilization to produce embryos |
| 04/16/2002 | US6372250 Non-invasive gene targeting to the brain |
| 04/16/2002 | US6372249 Senscent cell-derived inhibitors of DNA synthesis |
| 04/16/2002 | US6372221 Immunogenic constructs comprising flaviviruses or flavivirus derivatives |
| 04/16/2002 | US6372217 Methods for the treatment of CD7+ viral infection with TXU-7-PAP |
| 04/16/2002 | US6372215 Monoclonal antibodies to human CD6 |
| 04/16/2002 | US6372214 Antibodies specific for native PrPSc |
| 04/16/2002 | US6372212 Chitinase materials and methods |
| 04/16/2002 | US6372211 Methods and compositions for controlling insects |
| 04/16/2002 | US6372208 Method of reducing an immune response to a recombinant virus |
| 04/16/2002 | US6372207 IFNAR2/IFN complex |
| 04/16/2002 | US6372206 Orally-administered interferon-TAU compositions and methods |
| 04/16/2002 | US6372045 Apparatus for preparing sample cartridges for a particle acceleration device |
| 04/16/2002 | CA2355334A1 Pharmaceutical preparations and methods for inhibiting tumors |
| 04/16/2002 | CA2235752C Process for preparing o-acetylserine, l-cysteine and l-cysteine-related products |
| 04/16/2002 | CA2217565C Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 04/16/2002 | CA2162710C Dyes designed for high sensitivity detection of double-stranded dna |
| 04/16/2002 | CA2046607C Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 04/13/2002 | CA2321189A1 Antisense oligonucleotides directed toward mammalian vegf receptor genes and uses thereof |
| 04/12/2002 | CA2358831A1 Gene expression monitoring using universal arrays |
| 04/11/2002 | WO2002029388A2 Fluorescence detection |
| 04/11/2002 | WO2002029120A1 Method of detecting norwalk-like virus (gii) |
| 04/11/2002 | WO2002029119A1 Method of detecting norwalk-like virus (gi) |
| 04/11/2002 | WO2002029118A1 A kit for detecting non-pathogenic or pathogenic influenza a subtype h5 virus |
| 04/11/2002 | WO2002029117A2 Methods and probes for detection and/or quantification of nucleic acid sequences |
| 04/11/2002 | WO2002029111A1 Methods for introducing biomolecules and uses thereof |
| 04/11/2002 | WO2002029104A2 Tumor marker and methods of use |
| 04/11/2002 | WO2002029102A1 Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips |
| 04/11/2002 | WO2002029097A2 Methods relating to polymorphisms in the human gpr10 gene |
| 04/11/2002 | WO2002029093A2 Method for selecting nucleic acids that bond with high-affinity to a target |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 04/11/2002 | WO2002029084A2 Industrial-scale serum-free production of recombinant factor vii in mammalian cells |
| 04/11/2002 | WO2002029083A2 Industrial-scale serum-free production of recombinant proteins in mammalian cells |
| 04/11/2002 | WO2002029081A1 Vector facilitated sequence addition |
| 04/11/2002 | WO2002029080A2 Fermentation process for the preparation of l-amino acids using strains of the family enterobacteriaceae |
| 04/11/2002 | WO2002029076A1 Methods and compositions for directed microwave chemistry |
| 04/11/2002 | WO2002029075A2 Multiple inducible gene regulation system |
| 04/11/2002 | WO2002029074A2 Genetic immunisation against cervical carcinoma |
| 04/11/2002 | WO2002029073A2 Gene delivery vectors for stem cells |
| 04/11/2002 | WO2002029072A2 Targetting molecules for adenoviral vectors |
| 04/11/2002 | WO2002029071A2 Methods and compositions relating to the generation of partially transgenic organisms |
| 04/11/2002 | WO2002029070A2 Genetic functions required for gene silencing in maize |
| 04/11/2002 | WO2002029069A2 A nitrate-responsive plant root specific transcriptional factor |
| 04/11/2002 | WO2002029068A2 Virus-based amplification vector for plants |
| 04/11/2002 | WO2002029067A1 EXPRESSION VECTORS WITH MODIFIED ColE1 ORIGIN OF REPLICATION FOR CONTROL OF PLASMID COPY NUMBER |
| 04/11/2002 | WO2002029066A1 Antisense inhibition of caspase 6 expression |
| 04/11/2002 | WO2002029065A2 Retroviral vectors containing internal ribosomal entry sites |
| 04/11/2002 | WO2002029064A2 Method for establishing germ cell-specific gene expression |
| 04/11/2002 | WO2002029062A2 Cytokine proteins |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029060A2 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | WO2002029059A2 Nogo receptor homologs |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029057A2 32144, a human fatty acid amide hydrolase and uses thereof |
| 04/11/2002 | WO2002029056A2 Mini-dystrophin nucleic acid and peptide sequences |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029053A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/11/2002 | WO2002029052A2 Regulation of human secretin receptor-like gpcr |
| 04/11/2002 | WO2002029051A2 Human secretin receptor-like gpcr |
| 04/11/2002 | WO2002029050A2 Regulation of human secretin receptor-like gpcr |
| 04/11/2002 | WO2002029049A2 Regulation of human sodium-dependent monoamine transporter |
| 04/11/2002 | WO2002029048A2 Regulation of human sodium-dependent neurotransmitter transporter |
| 04/11/2002 | WO2002029047A2 Regulation of human gpcr-like protein |
| 04/11/2002 | WO2002029046A1 Hepatocyte nuclear factor 4-gamma: hnf4-gamma |
| 04/11/2002 | WO2002029045A2 Method for the production of vitamin k-dependent proteins |
| 04/11/2002 | WO2002029044A2 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | WO2002029043A1 Method of identifying target gene of transcription factor and method of isolation |
| 04/11/2002 | WO2002029042A2 48120, 23479, and 46689, novel human hydrolases and uses thereof |
| 04/11/2002 | WO2002029041A2 32146 and 57259, novel human transporters and uses thereof |
| 04/11/2002 | WO2002029040A2 25219, a novel human aminotransferase and uses therefor |
| 04/11/2002 | WO2002029039A2 47316, a novel human g-protein and uses therefor |
| 04/11/2002 | WO2002029038A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | WO2002029036A2 Lipid metabolism enzymes |
| 04/11/2002 | WO2002029035A2 Method to alter sugar moieties |
| 04/11/2002 | WO2002029034A2 Exbb-exbd-tonb gene cluster of pseudomonas putida dot-t1e conferring tolerance to aromatic compounds and resistance to antibiotics |
| 04/11/2002 | WO2002029032A2 Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| 04/11/2002 | WO2002029031A2 Isoprenoid-dependent ras anchorage (idra) proteins |
| 04/11/2002 | WO2002029030A2 Ethanol production |
| 04/11/2002 | WO2002029028A2 Brassicaceae with altered floral development |
| 04/11/2002 | WO2002029026A2 Human proteases and polynucleotides encoding the same |
| 04/11/2002 | WO2002029025A2 Factor vii glycoforms |
| 04/11/2002 | WO2002029023A1 Nicastrin protein |
| 04/11/2002 | WO2002029022A2 Chlorophyllases |
| 04/11/2002 | WO2002029021A2 Biotechnological method for preparing carboxylic acids with a hydroxy-nitrogen heterocycle |
| 04/11/2002 | WO2002029019A2 2.5-diketo-d-gluconic acid reductases and methods of use |
| 04/11/2002 | WO2002029018A2 Divinyl ether synthase gene and protein, and uses thereof |
| 04/11/2002 | WO2002029017A2 Nls-tankyrase fusion proteins and their use in screening methods |
| 04/11/2002 | WO2002029016A2 Thermostable polymerase based on thermococcus pacificus |
| 04/11/2002 | WO2002029014A2 Stem cell differentiation-inducing promoter |
| 04/11/2002 | WO2002029009A1 Cells engineered to contain genes of interest without drug resistance gene markers and materials and methods therefor |
| 04/11/2002 | WO2002029007A2 Bacteria used for oxidising arsenic, method for selecting same and uses thereof for treating media containing arsenic |